Invectys Strengthens Advisory Board with the Appointment of Dennis J. Purcell, Life Sciences Industry Veteran and Founder of Aisling Capital LLC Paris, France, May 05, 2020 (GLOBE NEWSWIRE) -- Invectys SA, a clinical-stage immuno-oncology company developing novel therapies for the treatment of advanced cancers, today announced the...

Tempus to Participate in the NCI-MATCH Clinical Trial Having met rigorous qualifications, Tempus joins a select group of commercial and academic laboratories designated to cast a wider net for patients to enter the trial CHICAGO, Aug. 02, 2018 (GLOBE...